Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.94 USD | +1.10% | +4.44% | -27.69% |
Mar. 26 | Enveric Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 19 | Sector Update: Health Care Stocks Rise Late Afternoon | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-28.95% | 6.78M | |
+20.26% | 42.68B | |
-2.28% | 42.4B | |
+45.21% | 40.04B | |
-6.20% | 28.31B | |
+6.45% | 24.94B | |
-21.62% | 18.96B | |
+30.49% | 12.3B | |
-2.87% | 11.95B | |
-3.64% | 11.55B |
- Stock Market
- Equities
- ENVB Stock
- News Enveric Biosciences, Inc.
- Enveric Biosciences Surging on Plans to Sell Cannabinoid IP Portfolio, Focus Shift to Psilocin Therapies